微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 7.39% | 2.92% | 76.37% | 26/132 | 0.36% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 4.19% | 16.71% | 227.34% | 37/132 | 1.85% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 1.28% | 0% | -84.5% | 62/132 | 1.06% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 8.26% | 63.56% | 15.04% | 40/132 | 3.1% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 7.18% | 59.91% | 100% | 41/132 | 4.78% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 3.59% | 48.96% | 180.47% | 55/132 | 3.08% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 1.28% | -57.62% | -74.65% | 67/132 | 1.67% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 5.05% | -96.55% | 12.47% | 69/132 | 5.12% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 4.49% | -96.81% | 86.31% | 68/132 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 2.41% | -98.31% | -20.2% | 72/132 | 3.81% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 3.02% | -97.88% | -97.94% | 43/132 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 146.56% | 333.35% | 3.99% | 1/132 | 13.36% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 140.94% | 5606.07% | -0.92% | 1/132 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 142.25% | 61947.82% | -0.32% | 1/132 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 142.71% | 7035.5% | 321.97% | 1/132 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 33.82% | 142.26% | 1269.23% | 14/132 | 17.4% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 2.47% | -87.46% | 1173.91% | 99/132 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | -0.23% | -101.62% | -111.5% | 113/132 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 2% | -26.47% | -85.67% | 73/132 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 13.96% | 193.44% | -29.1% | 71/132 | 25.69% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 19.69% | 476.48% | 38.27% | 27/132 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 14.24% | 516.37% | 423.53% | 31/132 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 2.72% | 216.24% | 118.21% | 31/132 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | -14.94% | -59.79% | -185.66% | 114/132 | 14.38% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | -5.23% | -14.44% | -52.92% | 65/132 | 10.49% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | -3.42% | 15.76% | -46.15% | 73/132 | 6.73% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | -2.34% | -25.81% | 74.97% | 56/132 | 2.72% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | -9.35% | 24.17% | -104.6% | 103/132 | 12.98% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | -4.57% | 22.67% | -12.56% | 53/132 | 7.16% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | -4.06% | -26.88% | -118.28% | 56/132 | 3.21% | 明德生物 | 14.54% | 行业排名> |
| 2018-03-31 | -1.86% | -78.85% | 84.91% | 51/132 | 2.62% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | -12.33% | 9% | -108.63% | 100/132 | 13.82% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | -5.91% | 48.16% | -84.69% | 48/132 | 9.43% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | -3.2% | 61.07% | -207.69% | 55/132 | 5.9% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | -1.04% | 56.49% | 92.32% | 44/132 | 2.66% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | -13.55% | 40.18% | -18.86% | 77/132 | 16.21% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | -11.4% | -24.18% | -38.69% | 39/132 | 8.69% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | -8.22% | -71.97% | -243.93% | 49/132 | 6.26% | 明德生物 | 23.29% | 行业排名> |
| 2016-03-31 | -2.39% | -6.22% | 89.45% | 34/132 | 2.14% | 健帆生物 | 7.75% | 行业排名> |
| 2015-12-31 | -22.65% | -109.14% | -146.73% | 61/132 | 15.95% | 大博医疗 | 55.39% | 行业排名> |
| 2015-09-30 | -9.18% | -127.79% | -92.05% | 33/132 | 7.79% | 鱼跃医疗 | 17.33% | 行业排名> |
| 2015-06-30 | -4.78% | -5411.11% | -112.44% | 45/132 | 7.77% | 明德生物 | 29.93% | 行业排名> |
| 2015-03-31 | -2.25% | -4600% | 79.22% | 34/132 | 3.2% | 中源协和 | 14.44% | 行业排名> |